Gulf Pharmaceutical Industries P.S.C Future Growth
Future criteria checks 0/6
Gulf Pharmaceutical Industries P.S.C is forecast to grow revenue at 4.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 16.9% |
| Revenue growth rate | 4.7% |
| Future return on equity | -1.0% |
| Analyst coverage | Low |
| Last updated | 04 Mar 2024 |
Recent future growth updates
Recent updates
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too
Jan 15
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking
Nov 04Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals
Mar 26Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.
Feb 08Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1,798 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 1,694 | N/A | 76 | 8 | 1 |
| 12/31/2023 | 1,638 | -104 | 65 | 92 | N/A |
| 9/30/2023 | 1,587 | -128 | -7 | 44 | N/A |
| 6/30/2023 | 1,637 | -85 | -54 | -2 | N/A |
| 3/31/2023 | 1,652 | -38 | -42 | 16 | N/A |
| 12/31/2022 | 1,616 | -34 | -46 | 19 | N/A |
| 9/30/2022 | 1,651 | -28 | -68 | -7 | N/A |
| 6/30/2022 | 1,598 | 0 | 13 | 75 | N/A |
| 3/31/2022 | 1,398 | 64 | 10 | 59 | N/A |
| 12/31/2021 | 1,143 | 47 | 2 | 46 | N/A |
| 9/30/2021 | 858 | -104 | -42 | -21 | N/A |
| 6/30/2021 | 682 | -138 | -117 | -101 | N/A |
| 3/31/2021 | 632 | -203 | -145 | -125 | N/A |
| 12/31/2020 | 573 | -247 | -184 | -168 | N/A |
| 9/30/2020 | 540 | -184 | -238 | -229 | N/A |
| 6/30/2020 | 376 | -377 | -240 | -224 | N/A |
| 3/31/2020 | 295 | -472 | -179 | -159 | N/A |
| 12/31/2019 | 302 | -494 | -119 | -85 | N/A |
| 9/30/2019 | 265 | -957 | 10 | 62 | N/A |
| 6/30/2019 | 388 | -840 | 31 | 84 | N/A |
| 3/31/2019 | 567 | -716 | 87 | 145 | N/A |
| 12/31/2018 | 720 | -612 | 127 | 179 | N/A |
| 9/30/2018 | 928 | -20 | 72 | 136 | N/A |
| 6/30/2018 | 1,106 | 80 | 136 | 200 | N/A |
| 3/31/2018 | 1,085 | 70 | 33 | 113 | N/A |
| 12/31/2017 | 1,155 | 95 | -5 | 81 | N/A |
| 9/30/2017 | 1,293 | 142 | N/A | 234 | N/A |
| 6/30/2017 | 1,275 | 145 | N/A | 234 | N/A |
| 3/31/2017 | 1,418 | 178 | N/A | 264 | N/A |
| 12/31/2016 | 1,455 | 212 | N/A | 268 | N/A |
| 9/30/2016 | 1,391 | 205 | N/A | 261 | N/A |
| 6/30/2016 | 1,407 | 215 | N/A | 242 | N/A |
| 3/31/2016 | 1,391 | 214 | N/A | 235 | N/A |
| 12/31/2015 | 1,470 | 230 | N/A | 183 | N/A |
| 9/30/2015 | 1,510 | 226 | N/A | 117 | N/A |
| 6/30/2015 | 1,449 | 235 | N/A | 161 | N/A |
| 3/31/2015 | 1,443 | 228 | N/A | 96 | N/A |
| 12/31/2014 | 1,388 | 204 | N/A | 40 | N/A |
| 9/30/2014 | 1,382 | 224 | N/A | 131 | N/A |
| 6/30/2014 | 1,427 | 231 | N/A | -22 | N/A |
| 3/31/2014 | 1,425 | 238 | N/A | 79 | N/A |
| 12/31/2013 | 1,362 | 230 | N/A | 108 | N/A |
| 9/30/2013 | 1,282 | 215 | N/A | 26 | N/A |
| 6/30/2013 | 1,247 | 207 | N/A | 140 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if JULPHAR's forecast earnings growth is above the savings rate (14.3%).
Earnings vs Market: Insufficient data to determine if JULPHAR's earnings are forecast to grow faster than the AE market
High Growth Earnings: Insufficient data to determine if JULPHAR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: JULPHAR's revenue (4.7% per year) is forecast to grow slower than the AE market (6.3% per year).
High Growth Revenue: JULPHAR's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: JULPHAR is forecast to be unprofitable in 3 years.